Daewon Pharm (003220) — Capital Reinvestment Ratio

Latest as of December 2025: 0.43x

Daewon Pharm (003220) has a Capital Reinvestment Ratio of 0.43x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩30.61 Billion) in capital expenditures (₩13.07 Billion). See free cash flow generation of Daewon Pharm to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.43x
Capex / Operating Cash Flow

Operating Cash Flow

₩30.61 Billion
KRW

Capital Expenditures

₩13.07 Billion
KRW

Data as of

Dec 2025
Most recent filing

Daewon Pharm Capital Reinvestment Ratio (2011–2025)

This chart tracks Daewon Pharm's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for Daewon Pharm (2011–2025)

Year-by-year Capital Reinvestment Ratio for Daewon Pharm from 2011 to 2025. For live market cap and broader valuation context, see how much is Daewon Pharm worth.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 1.00x ₩42.31 Billion ₩42.13 Billion ▼ -44.2%
2024 1.78x ₩30.04 Billion ₩53.58 Billion ▲ +347.8%
2023 0.40x ₩51.73 Billion ₩20.61 Billion ▼ -0.7%
2022 0.40x ₩33.33 Billion ₩13.37 Billion ▲ +119.0%
2021 0.18x ₩22.41 Billion ₩4.10 Billion ▼ -59.7%
2020 0.45x ₩24.95 Billion ₩11.35 Billion ▼ -57.4%
2019 1.07x ₩30.97 Billion ₩33.03 Billion ▲ +4.6%
2018 1.02x ₩40.03 Billion ₩40.82 Billion ▼ -70.4%
2017 3.45x ₩4.27 Billion ₩14.71 Billion ▲ +248.6%
2016 0.99x ₩20.79 Billion ₩20.57 Billion ▲ +29.0%
2015 0.77x ₩25.82 Billion ₩19.80 Billion ▼ -15.5%
2014 0.91x ₩17.45 Billion ₩15.84 Billion ▲ +13.6%
2013 0.80x ₩12.32 Billion ₩9.85 Billion ▲ +234.6%
2012 0.24x ₩13.83 Billion ₩3.30 Billion ▼ -58.0%
2011 0.57x ₩17.93 Billion ₩10.19 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow